InvestorsHub Logo
Followers 95
Posts 11595
Boards Moderated 0
Alias Born 12/27/2011

Re: Bing420 post# 1225

Saturday, 10/29/2016 2:32:49 PM

Saturday, October 29, 2016 2:32:49 PM

Post# of 9941
According to their investor presentation, they are scheduled to report on Phase 1/2a Clinical trials on INM-750 their EB drug in Q4, 2016 and initiate Phase 1 of their glaucoma drug INM-085 in the same quarter. Perhaps the market is anticipating some news on that.

Les

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News